AzTrials
AzTrials

Spinal Cord InjuryCARE trainingNCT06296771

The Effect of a Combined Aerobic and Resistance Exercise (CARE) Training Programme on Cardiometabolic Outcomes in Individuals With Chronic Spinal Cord Injury: A Randomised Controlled Trial

A study testing Dietary energy restriction group (D) and Dietary energy restriction and exercise group (D+E) in people with Spinal Cord Injury, run by University of Bath at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this study is to investigate the effectiveness of an 8-week dietary energy restriction with exercise or dietary energy restriction alone on the cardiometabolic health outcomes of individuals with chronic spinal cord injury. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Spinal Cord Injury
What is being tested?
Dietary energy restriction group (D) and Dietary energy restriction and exercise group (D+E)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteUnited Kingdom
Study dates
22 May 2024to 22 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The inclusion criteria for participation in this study are that patients have a chronic SCI that occurred at least one year before, an age range between 18 and 65 years, and sufficient upper limb function to engage in the exercise intervention. Participants must self-report that they use a wheelchair for the majority of their waking hours, namely 75% of their day, and have continually maintained a stable weight within a range of ± 3 kg over the duration of the previous three months.

Who cannot join

  • The study will exclude participants who have provided information about their medical conditions, such as unresolved pressure sores, urinary tract infections, active medical conditions that may be a contraindication to exercise testing (ACSM Exercise Testing Guidelines), or current musculoskeletal symptoms of the upper extremities. Individuals who have self-reported the use of medication for type 2 diabetes or pharmaceuticals that influence glucose metabolism will be excluded from involvement in the research.

Trial locations and contacts

1 site in 1 country.

Chatwalai Sonthikul, Master degree contact

+447787548735

cs2976@bath.ac.uk

United Kingdom1 site
  • University of Bath

    Bath, England, BA2 7AY

    James Bilzon, PhD, jb438@bath.ac.uk

    Jennifer Maher, PhD, jilm92@bath.ac.uk

Other trials in United Kingdom

About this study

The goal of this study is to investigate the effectiveness of an 8-week dietary energy restriction with exercise or dietary energy restriction alone on the cardiometabolic health outcomes of individuals with chronic spinal cord injury. This study is a randomised controlled trial conducted at a single centre, consisting of two parallel arms. The main questions it aims to answer are:

  1. the effectiveness of an 8-week dietary energy restriction with exercise or dietary energy restriction alone on cardiometabolic disease biomarker outcomes in individuals with chronic SCI
  2. the effectiveness of an 8-week dietary energy restriction with exercise or dietary energy restriction alone on fitness and health outcomes.

Twenty-one participants will be randomly assigned in a 2:1 allocation ratio. The participants will be assigned to either the dietary energy restriction and exercise group (D+E) group, which combines dietary energy restriction and exercise intervention, or the dietary energy restriction group (D) group, which just undergoes dietary energy restriction using sealed envelopes.

Read the detailed description

This study is a randomised controlled trial conducted at a single centre, consisting of two parallel arms. The recruitment of 21 people with a chronic spinal cord injury will begin through the distribution of advertisements across several channels, including national disability charity websites, internet forums, and social media networking sites. Interested potential participants will be asked to contact the principal researcher for further information via email or telephone correspondence. The principal researcher will email a participant information sheet and health screening questionnaire and conduct a follow-up phone call \>48 hours after the participant expresses their initial interest to fully explain what the trial entails and answer any questions. If the potential participant indicates that they wish to take part in the study, the first visit will be scheduled. On the first visit, participants will be asked to provide written informed consent. The study will involve a total of 2 assessment visits (~5 hours each), which will take place before and after an 8-week intervention. For these visits, participants will be asked to arrive after an overnight fast (\>10 hours). During these visits, we will first assess anthropometrics by dual-energy X-ray absorptiometry and peripheral quantitative computed tomography. A principal researcher will adipose tissue biopsy by procedure known as \'needle aspiration\' and insert a cannula into a vein in the forearm to allow regular blood samples to be taken for 2 hours following the oral consumption of glucose drinks. During the 2-hour glucose test, participants will be asked to complete two questionnaires on pain, and quality of life. Participants will then be given lunch and asked to perform a maximal exercise test on an arm-crank ergometer, muscular strength by hand-held dynamometer, and balance by functional reach test. Participants will be asked to wear a physical activity monitor for 5 days following the initial visit and in the final week of the 8-week period. Participants will also be asked to complete a questionnaire about the satisfaction and perceived benefits of the programme intervention on week 8. After baseline testing, eligible consenting participants will be randomly allocated (2:1) to a dietary energy restriction with exercised (D+E) or dietary energy restriction alone (D) using a sealed envelope and balance groups for key characteristics (age, sex, and and level of injury) at baseline. The participants allocated to the D group will receive instructions to reduce meal portions for a total calorie deficit of 5000 kcal per week and maintain their regular physical activity routine for the duration of eight weeks. This deficit is computed by subtracting the participants\' energy expenditure, as measured by ActiheartTM. The individuals within the D+E group will be instructed to reduce their habitual energy intake by 5,000 kcal per week while taking part in physical exercise with a frequency of three sessions per week of HIIT and two sessions per week of resistance exercise throughout a duration of 8 weeks. Throughout the exercise training sessions, participants will receive instructions to employ a chest-worn heart rate (HR) monitor.

Being tested
Dietary energy restriction group (D), Dietary energy restriction and exercise group (D+E)
Keywords
Chronic spinal cord injury, combined aerobic and resistance exercise training programme, cardiometabolic outcomes, high intensity interval training, resistance training
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dietary energy restriction group (D)Other

    The participants allocated to the dietary energy restriction group will receive instructions to change their usual dietary intake and maintain their regular physical activity routine for the duration of eight weeks.

    The dietary energy restriction depends on a total calorie deficit of 5000 kcal per week, achieved by the consumption of reduced meal portions. This deficit is computed by subtracting the participants\' energy expenditure, as measured by ActiheartTM, rather than relying on reported energy intake. This approach is employed to reduce potential difficulties arising from participants under-reporting their food consumption. The energy deficit is calculated by multiplying the weight of each food item recorded over a 5-day period by an individual factor obtained from energy expenditure data. This calculation enables the determination of the required energy intake for the intervention period.

  • Dietary energy restriction and exercise group (D+E)Other

    The individuals within the dietary energy restriction and exercise group will be instructed to reduce their habitual energy intake by 5,000 kcal per week while taking part in physical exercise with a frequency of three sessions per week of HIIT and two sessions per week of resistance exercise throughout a duration of 8 weeks. Sessions can be performed in any order, but we will recommend alternating HIIT and resistance training days and taking the two rest days separately to allow for recovery.

    The exercise programme will start the session by participating in a gentle stretching routine with the objective of reducing the effects of exercise-induced shoulder discomfort. The treatment focuses on the four main muscle groups in the upper body: the latissimus dorsi, the triceps, the rhomboid, the pectoral, and the upper trapezius. Each pose is held in the stretched position for a length of 15 seconds throughout each set, for a total of 4 sets.

Study groups in NCT06296771
Study groupRoleWhat they receive
Dietary energy restriction and exercise group (D+E)ExperimentalNot described
Receives: Other: Dietary energy restriction and exercise group (D+E)
Dietary energy restriction group (D)Active comparatorNot described
Receives: Other: Dietary energy restriction group (D)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lipid profile

    Blood sample

    Measured: 8 weeks

  2. Fasting insulin concentration

    Serum insulin concentration

    Measured: 8 weeks

  3. Insulin sensitivity

    Serum insulin concentration

    Measured: 8 weeks

Secondary outcomes (17)
  1. Resting matabolic rate

    Measured using indirect calorimetry

    Measured: 8 weeks

  2. Body mass

    Measured using electronic wheelchair scales

    Measured: 8 weeks

  3. Waist and hip circumference

    Measured using a non-metallic tape

    Measured: 8 weeks

  4. Height

    Measured using a non-metallic tape

    Measured: 8 weeks

  5. Total body fat percentage

    Measured using duel-energy x-ray absorptiometry

    Measured: 8 weeks

  6. Total Fat-Free Mass

    Measured using duel-energy x-ray absorptiometry

    Measured: 8 weeks

  7. Visceral Adipose Tissue

    Measured using duel-energy x-ray absorptiometry

    Measured: 8 weeks

  8. Total Fat Mass

    Measured using duel-energy x-ray absorptiometry

    Measured: 8 weeks

  9. Muscle, adipose and bone cross-sectional areas around the tibia and femur

    Measured using Peripheral quantitative computed tomography

    Measured: 8 weeks

  10. Bone geometry and tissue densities around the tibia and femur

    Measured using peripheral quantitative computed tomography

    Measured: 8 weeks

  11. adipose tissue

    Measured using adipose tissue biopsy

    Measured: 8 weeks

  12. Upper extremity muscle strength

    Handheld dynamometer

    Measured: 8 weeks

  13. Balance

    The Modified Functional Reach Test

    Measured: 8 weeks

  14. Health-related quality of life

    Measured using a validated questionnaire

    Measured: 8 weeks

  15. Shoulder Pain

    Measured using a validated questionnaire

    Measured: 8 weeks

  16. Energy intake and dietary macronutrient composition

    Estimated using a 5-day weighed food diary

    Measured: 8 weeks

  17. Energy expended in different physical activity intensities (MET categories) (kJ or kcal)

    Energy expended in different physical activity intensities across 5-days (MET categories) (kJ or kcal)

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2024
  2. Study start22 May 2024 (estimated)
  3. Primary completion22 Feb 2025 (estimated)
  4. Study completion22 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
21 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06296771
Sponsor's protocol ID
12345678280233
Other IDs
UBath
Acronym
CARE training
Status last verified
Feb 2024
First submitted
29 Feb 2024
Last updated
6 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Dietary energy restriction group (D) and Dietary energy restriction and exercise group (D+E) in people with Spinal Cord Injury, run by University of Bath at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chatwalai Sonthikul, Master degree (+447787548735, cs2976@bath.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lipid profile (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in